Emergent BioSolutions Inc

NetDania - New 12 months Low: Emergent BioSolutions Inc

21 May 2019 09:45:28 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

20 May 2019 10:04:52 By NetDania Notify

Emergent BioSolutions to Participate in Series of Investor Conferences

20 May 2019 06:31:26 By Nasdaq GlobeNewswire

Emergent BioSolutions Prepares for Initial Shipments of AV7909 Anthrax Vaccine Candidate into the Strategic National Stockpile

15 May 2019 16:06:18 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

15 May 2019 09:45:20 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

14 May 2019 09:52:10 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

13 May 2019 11:33:57 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

10 May 2019 09:45:57 By NetDania Notify

NetDania - New 12 months Low: Emergent BioSolutions Inc

09 May 2019 10:55:31 By NetDania Notify

Emergent BioSolutions to Hold Annual Meeting of Stockholders on Thursday, May 23, 2019 at 9:00 AM EDT; Webcast Will Be Available

09 May 2019 06:31:06 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: Emergent BioSolutions Inc

07 May 2019 15:51:56 By NetDania Notify

Emergent BioSolutions Reports First Quarter 2019 Financial Results

02 May 2019 16:05:13 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release First Quarter 2019 Financial Results and Conduct a Conference Call on May 2, 2019

18 Apr 2019 07:22:22 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Interim Results From Phase 2 Study Evaluating CHIKV-VLP, Chikungunya Virus Vaccine Candidate

16 Apr 2019 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Awarded U.S. Department of State Contract to Supply Medical Countermeasures For Chemical Warfare Agents

28 Feb 2019 16:45:42 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results

21 Feb 2019 16:05:29 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Appointment of Seamus Mulligan to its Board of Directors

12 Feb 2019 06:30:20 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on February 21, 2019

07 Feb 2019 09:35:05 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Appointment of Robert G. Kramer, Sr. to Its Board of Directors

24 Jan 2019 07:01:01 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Preliminary 2018 Financial Results and Provides 2019 Financial Forecast

07 Jan 2019 06:30:56 By Nasdaq GlobeNewswire